Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/Philippines FDA/Varivax

Approved

STANDARD

Varivax

Merck Sharp & Dohme Corp.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 862a10eb4eb167e7
Company: Merck Sharp & Dohme Corp.
Type: Standard

Approval Details

Approval Id: 862a10eb4eb167e7
Drug Approval Philippines Name: Varivax
Product Name: Varivax
Registration Number: BR-955
Brand Name: Varivax
Generic Name: Varicella Virus Vaccine, Live
Dosage Form: Lyophilized Powder For Solution for Injection (SC)
Dosage Strength: 1350 PFU/0.5 mL
Manufacturer: Merck Sharp & Dohme Corp.
Importer: Merck Sharp & Dohme (I.A.) Corporation
Company Detail Path: /organization/merck-sharp-and-dohme-corp-united-states
Issuance Date: 28 June 2024
Expiry Date: 14 July 2029
Pharmacologic Category: Vaccine
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

862a10eb4eb167e7

Type

Standard

Back to Philippines FDA Approvals

Varivax - Philippines FDA Drug Approval Details